Huyghe Eric, Blanc Anthony, Nohra Joe, Khedis Mehdi, Labarthe Pierre, Rouge Daniel, Plante Pierre
Service d'Urologie et Andrologie, Hôpital Paule de Viguier, Toulouse, France.
Prog Urol. 2007 Jun;17(4):789-93. doi: 10.1016/s1166-7087(07)92293-9.
To analyse technical innovations, their results and the changing legislation in France concerning sterilizing or contraceptive vas deferens surgery.
A review of the literature was performed using the key words: male/contraception/vas deferens. From the 332 research articles obtained from PUBMED, we selected 54 articles for their methodological quality and the importance of their results.
Vasectomy remains the only validated vas deferens surgical technique. Although microsurgical reconstructive techniques have improved the vas deferens restoration rate, vasectomy must be considered to be a definitive method of sterilization. The other contraceptive (reversible) vas deferens surgical techniques have not demonstrated sufficient efficacy to be used outside of the context of clinical trials. However the encouraging results ofsome ofthese studies could allow their development in the intermediate term. From a legal point of view, since the reform of sterilizing surgery in Article L2123-1 of the French Public Health Act, vasectomy is now authorized in a regulatory framework.
The urology community must take into account progress in the field of contraceptive vas deferens surgical techniques.
分析法国在输精管绝育或避孕手术方面的技术创新、其成果以及不断变化的立法情况。
使用关键词“男性/避孕/输精管”进行文献综述。从通过PUBMED获取的332篇研究文章中，我们根据其方法学质量和结果的重要性选择了54篇文章。
输精管结扎术仍然是唯一经过验证的输精管手术技术。尽管显微外科重建技术提高了输精管复通率，但输精管结扎术仍应被视为一种确定性的绝育方法。其他避孕（可逆性）输精管手术技术尚未证明有足够的疗效可在临床试验背景之外使用。然而，其中一些研究的令人鼓舞的结果可能会使其在中期得到发展。从法律角度来看，自法国《公共卫生法》第L2123 - 1条绝育手术改革以来，输精管结扎术现在已在监管框架内获得授权。
泌尿外科界必须考虑输精管避孕手术技术领域的进展。
